logo-loader

Orgenesis CEO talks through most recent collaborations: 3D cell printing and exosome technologies

Published: 09:41 01 May 2019 EDT

Orgenesis Inc (NASDAQ:ORGS) CEO Vered Caplan tells Proactive Investors the cell therapy development company has inked a collaboration and licensing deal with ExcellaBio Ltd for exosome-related technologies, in addition to a recent collaboration agreement with Digilab Inc to develop a live cell printing process and systems to automate the production of 3D cell and tissue structures.

Poseidon Nickel signs binding agreement with Mineral Resources to divest...

Departing Poseidon Nickel Ltd (ASX:POS, OTC:PSDNF) CEO Craig Jones and incoming CEO Brendan Shalders join Proactive’s Jonathan Jackson to discuss the divestment of Lake Johnston to Mineral Resources Ltd (ASX:MIN). Jones, who has played a pivotal role in this strategic move, shared insights on...

4 hours, 31 minutes ago